Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CLOZAPINE
- Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
- Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
- A Prospective, Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
- The Safety of Paxlovid in Hemodialysis Patients With Covid-19
- Biomarkers in Clozapine-responding Schizophrenia
- Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
- Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- Acetazolamide for Treatment Resistant Schizophrenia
- Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18
- Antipsychotic Response to Clozapine in B-SNIP Biotype-1 (Clozapine)
- Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
- SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
- Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder
- Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia
- Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia
- The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
- SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
- Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
- Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime
- Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women
- Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- HDAC Inhibitor Augmentation to Clozapine
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adult
- Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
- The Optimal Treatment for Treatment-resistant Schizophrenia
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
- The Impact of Caffeine on Cognition in Schizophrenia
- Topiramate and Schizophrenia: Effects on Weight and Psychopathology
- Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study
- Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
- Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
- Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
- Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
- The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
- Clozapine-induced Hypersalivation - Feasibility Trial
- NRX-1074 in Early Course Schizophrenia
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Guideline vs Usual Treatment in Schizophrenic Adolescents
- Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
- Nicotinic Receptors and Schizophrenia
- Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)
- Pharmacovigilance in Gerontopsychiatric Patients
- Study of the Effect of Dosing on Clozapine Levels
- Metoclopramide as Treatment of Clozapine-induced Hypersalivation
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- Effects of Metformin and Fish Oil on Treatment With Clozapine
- Minocycline Augmentation to Clozapine
- Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- Minocycline for Schizophrenia
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- Vitamin D for Schizophrenia
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- An Open-Label Trial of Tocilizumab in Schizophrenia
- Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients
- The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
- Clozapine for Cannabis Use in Schizophrenia
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
- Alleviating the Metabolic Side Effects of Antipsychotic Medications
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
- Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients
- Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
- Risperidone and Desipramine in Alcohol Use and Schizophrenia
- Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine
- F-18 Altanserin PET Study of Patients Receiving Clozapine
- DAAOI-1 Treatment for Treatment-resistant Schizophrenia
- Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients
- Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
- GlyT-1 Inhibitor Treatment for Refractory Schizophrenia
- Optimization of Treatment and Management of Schizophrenia in Europe
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
- Caffeine for Motor Manifestations of Parkinson's Disease
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
- Clozapine and Olanzapine Treatment of Aggression
- Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients
- Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine
- The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia
- TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia
- Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Polypharmacy in Clozapine-resistant Schizophrenia
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- Treating Clozapine-induced Sinustachycardia With Bisoprolol
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia
- A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
- Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
- Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
- Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT)
- A New Pharmacotherapy for Alcohol Dependence: Olanzapine
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
- FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
- Cardio Risk of Acute Schizophrenia Olanzapine Duke
- Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
- A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
- A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia
- A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
- Effects of Modafinil on Olanzapine Weight Gain
- Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
- A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis
- A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
- First Episode Schizophrenia and Cannabis-Related Disorder Study
- The Effects of Rimonabant, on Weight and Metabolic Risk Factors
- Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
- Glucose and Lipid Metabolism on Antipsychotic Medication
- Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
- A Multicenter Study of NAP (AL-108) in Schizophrenia
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder
- Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
- Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
- Antipsychotic Polypharmacy in Schizophrenia
- Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
- Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
- Efficacy of Pimozide Augmentation for Clozapine Partial Response
- Tetrabenazine for Partial Responders
- Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
- Augmenting Clozapine With Sertindole - SERCLOZ
- Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
- Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
- Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
- The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients
- Risperidone Augmentation in Patients With Schizophrenia
- Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
- CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
- Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia
- Trial of Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia
- Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
- Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
- Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
- Janssen - Glucose Regulation/Risp/Olanz
- Pfizer/IVGTT/Ziprasidone/Olanzapine
- Clozapine IM and Aggression in Schizophrenic Patients
- Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
- Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
- Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
- Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
- Alcoholism and Schizophrenia: Effects of Clozapine
- Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
- Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia
- Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
- A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
- Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease
- Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
- Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
- Treating Drug-Resistant Childhood Schizophrenia
- Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
- Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
- Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
- Clozapine for Treatment-Resistant Mania
- CATIE- Schizophrenia Trial
- Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease
- Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
- Glycine and D-Cycloserine in Schizophrenia
Clinical trials list
click for details